Placement Pending
Sensei Biotherapeutics placement
US$200m raised
Announced 18 Feb 2026 · NASDAQ: SNSE · US$13850.00 cash per share
Advisers
Sensei Biotherapeutics
Issuer
- Financial adviser
- Legal adviser
- Sidley Austin

Team: Asher Rubin, John Butler, Istvan Hajdu, Nikita Ponomarev, Michael Rohr, Emily Chazen, Xi Zhao, Christine Seo, Nick DeAngelis, Sonia Gupta Barros, Kendell Lee, Eric Carlson, Adriana Tibbitts, Collin Marshall, Kayla Nguyen, Gregory Marrs, Christian Pilhofer, Ryan McLeod, Madeline Clasen, Christian Brause, Tyler J. Combest, Eric G. Hoffman, Raza Siddiqui
Lead managers
- Placement agent
- Issuer
- Sensei Biotherapeutics
- Issuer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Oncology, Drug Development
Similar deals
- Avenzo Therapeutics placement Jun 2026 · US$215m · Biotech
- BlossomHill Therapeutics IPO Aug 2026 · US$150m · Biotech
- Eikon Therapeutics IPO Feb 2026 · US$381m · Oncology
- Remix Therapeutics placement Jun 2026 · US$100m · Biotech
- Parabilis Medicines IPO Jun 2026 · US$670m · Biotech

